Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72808 record(s)

Req # A-2023-001482

The Drug Master File (MF) of the Degarelix Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

2302 page(s)
July 2024

Req # A-2023-001484

The Abbreviated New Drug Submission (ANDS) cover letter of the company (sponsor) who submitted the Degarelix ANDS.

Organization: Health Canada

2 page(s)
July 2024

Req # A-2023-001604

The most recent Certified Product Information Document (CPID) submitted for the Semaglutide Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

36 page(s)
July 2024

Req # A-2024-000001

All records related to the clarification requests and to the response received from Pfizer, including discussions and consultations between Health Canada’s Biologic and Radiopharmaceutical Drugs Directorate (BRDD) staff on the matter of the presence…

Organization: Health Canada

365 page(s)
July 2024

Req # A-2024-000150

All emails and email attachments held by the media relations team that were created between March 1, 2024 and May 7, 2024 mentioning "Highly pathogenic avian influenza" (HPAI) in cattle and/or bovine avian influenza.

Organization: Health Canada

32 page(s)
July 2024

Req # A-2024-000177

Any correspondence sent from Health Canada to Toronto Public Health since March 1, 2023 on the subject of Toronto's request for an exemption under the Controlled Drugs and Substances Act for the personal possession of certain substances.

Organization: Health Canada

70 page(s)
July 2024

Req # A-2024-000191

Information from Health Canada concerning the following material in any form: Dr. Dean Smith of Health Canada attended an Ad-Hoc Cluster meeting on August 24, 2023. The agenda of the notes, e- meeting, all meeting and presentation notes, summary…

Organization: Health Canada

27 page(s)
July 2024

Req # A-2024-000269

All Health Canada records related to the European ban of mancozeb, and all records related to whether Health Canada's Pest Management Regulatory Agency (PMRA) should do a special review of Mancozeb under the Pest Control Products Act from July…

Organization: Health Canada

256 page(s)
July 2024

Req # A-2024-000294

Discussions, reports, and written correspondence between Health Canada and GSK(GlaxoSmithKline) about acquiring and manufacturing a “pre pandemic bird flu vaccine” or a “bird flu vaccine” since January 1, 2023 to June 4, 2024.

Organization: Health Canada

0 page(s)
July 2024

Req # A-2024-000301

Certain information regarding this company's file status with your organization. Gestion Joe Robin Inc. (NEQ: 1172560311), Addresses: 6600 Choquette Boulevard, Saint-Hyacinthe, Quebec J2S 8L1; 1882-1890 Rue des Cascades, Saint-Hyacinthe,…

Organization: Health Canada

0 page(s)
July 2024
Date modified: